| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,661 |
4,306 |
$355K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,812 |
3,544 |
$224K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,084 |
1,073 |
$42K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
165 |
162 |
$35K |
| 90834 |
Psychotherapy, 45 minutes with patient |
480 |
290 |
$34K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
287 |
280 |
$22K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
217 |
217 |
$17K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
176 |
171 |
$12K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,675 |
1,651 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
2,767 |
2,601 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
99 |
99 |
$8K |
| 97810 |
|
265 |
95 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
288 |
280 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
370 |
357 |
$6K |
| 97811 |
|
266 |
96 |
$6K |
| 90686 |
|
778 |
765 |
$5K |
| 92551 |
|
660 |
652 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
95 |
94 |
$3K |
| 99188 |
|
284 |
283 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
34 |
33 |
$3K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$2K |
| 91322 |
|
12 |
12 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
164 |
163 |
$1K |
| 80061 |
Lipid panel |
67 |
66 |
$871.98 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31 |
30 |
$530.85 |
| 99173 |
|
392 |
385 |
$515.12 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$501.12 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$501.12 |
| 99177 |
|
98 |
98 |
$378.52 |
| 90656 |
|
42 |
42 |
$334.10 |
| 36416 |
|
112 |
108 |
$319.95 |
| 90651 |
|
19 |
19 |
$257.64 |
| 90480 |
|
12 |
12 |
$256.23 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
13 |
$217.08 |
| 96127 |
|
44 |
43 |
$166.09 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$110.65 |
| 85018 |
|
44 |
44 |
$110.01 |
| 80053 |
Comprehensive metabolic panel |
12 |
12 |
$79.86 |
| 90647 |
|
85 |
85 |
$0.00 |
| 90723 |
|
79 |
79 |
$0.00 |
| 90677 |
|
26 |
25 |
$0.00 |
| 87081 |
|
14 |
12 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| X5622 |
|
310 |
299 |
$0.00 |
| 90670 |
|
138 |
138 |
$0.00 |
| 90633 |
|
67 |
67 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |
| 90707 |
|
14 |
14 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
14 |
$0.00 |